SRTA stock Statistics — Strata Critical Medical, Inc. filings, insiders & smart money

Price and daily changeSign in

Earnings9 Nov 2026

52-week rangeSign inDay rangeSign in

Price chart (1D to 10Y)

Licensed market data — shown to members, not published to the open web.

Beta: Sign in
Shares outstandingAs of 2026-07-28 · filed common shares: 88.46M
Shares float: Sign in
Float %: Sign in
Insider ownershipDirectors and officers, from their latest Form 3/4/5 holding: 13.44%
Institutional ownership: Sign in
Short interestShare of shares outstanding, at settlement: 5.12%
Short ratioDays to cover, as published by FINRA: 5.52
Short volume (5D)Share of FINRA reporting-facility volume sold short, daily flow: 59.20%
Short volume (20D)Share of FINRA reporting-facility volume sold short, daily flow: 54.20%
Avg volume (10D)

Source: SEC filings. Information and analytics, not investment advice.

Rev growth (fwd)

Avg volume (3 months)

Gross marginTTM to Jun 26: 21.25%
Operating marginTTM to Jun 26: -7.97%
Net margin: —
EBITDA marginTTM to Jun 26: -1.61%
Return on equityNet income (TTM to Jun 26) ÷ average shareholders equity: 16.01%
Return on assetsNet income (TTM to Jun 26) ÷ average total assets: 13.62%

Sign in

Price / operating cash flow

P/FCF

EV / revenue

EV / EBITDA

EPSDiluted, TTM to Jun 26

0.49

EPS (fwd)

Cash & equivalentsas of Jun 26: $16.31M
Total cash: Sign in
Total debtBorrowings + finance and operating lease liabilities, as of Jun 26: $4.25M
Debt / equityas of Jun 26: 1.52%
Current ratioas of Jun 26: 2.64
Quick ratio(Cash + marketable securities + receivables) ÷ current liabilities, as of Jun 26: 1.45
Operating cash flowTTM to Jun 26: -$36.03M
Free cash flowUnadjusted FCF = CFO − capex · TTM to Jun 26: -$48.44M
TTM revenue / diluted shareDiluted, TTM to Jun 26: 2.98